Scinovex
articleTop 1% cited

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

European Journal of Endocrinology · 2006 · Vol. 154(6) · pp. 899–906

Abstract

Testosterone replacement therapy reduces insulin resistance and improves glycaemic control in hypogonadal men with type 2 diabetes. Improvements in glycaemic control, insulin resistance, cholesterol and visceral adiposity together represent an overall reduction in cardiovascular risk.

Hormonal and reproductive studiesPharmacology and Obesity TreatmentRegulation of Appetite and ObesityInternal medicineEndocrinologyMedicineType 2 diabetesInsulin resistanceTestosterone (patch)InsulinCrossover studyDiabetes mellitusPlacebo

MeSH terms

AgedBlood GlucoseDiabetes Mellitus, Type 2Double-Blind MethodHumansHypercholesterolemiaHypogonadismInsulin ResistanceMaleMiddle AgedTestosteroneCross-Over StudiesHormone Replacement TherapyAbdominal Fat
Citations
781
FWCI
27.67
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.